COMP <GO>
ARGX vs MRNA // EV/EBITDA & P/E VALUATION
argenx SE (NASDAQ) VS. Moderna Inc. (NASDAQ) • 15-METRIC TALLY: ARGX 7
— MRNA 4
■ METRIC PARITY
LAST: $892.87 (-0.56%) • MKT CAP: $55.72B
valuation
21.0x
LAST: $221.72 (-0.47%) • MKT CAP: $88.93B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARGX VS. MRNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARGX | MRNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 55.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | -34.10% | +44.00 | ARGX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 21.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | -2.32% | +4.53 | ARGX | /fcf-yield <GO> |
| Operating Margin | 13.90% | -60.00% | +73.90 | ARGX | /operating-margins <GO> |
| Net Profit Margin | 10.90% | -60.00% | +70.90 | ARGX | /net-margins <GO> |
| Revenue Growth (YoY) | 18.70% | -39.90% | +58.60 | ARGX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 15.07 | -11.33 | MRNA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | ARGX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 57.7 | -6.00 | MRNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.10 | -0.08 | MRNA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 32.0x | -4.40 | ARGX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $55.72B | $88.93B | -$33.21B | MRNA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARGX REV | MRNA REV | ARGX GROSS % | MRNA GROSS % | ARGX FCF | MRNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $1.94B | — | 55.3% | — | -$2.06B |
| FY 2024 | — | $3.24B | — | 54.8% | — | -$4.05B |
| FY 2023 | — | $6.85B | — | — | — | -$3.43B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARGX // BETA 1.02
MRNA // BETA 1.10